BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 10300702)

  • 1. How strong is your hand when the HMO opens the bid?
    Keegan AJ
    Healthc Financ Manage; 1986 May; 40(5):31-5. PubMed ID: 10300702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asking the right questions in HMO and PPO evaluation.
    Millikan DL
    Healthc Financ Manage; 1986 May; 40(5):38-41. PubMed ID: 10300703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riskier HMO payment for HMO-related hospitals.
    Rahn GJ; Traska MR
    Hospitals; 1987 Aug; 61(16):42-3. PubMed ID: 3610101
    [No Abstract]   [Full Text] [Related]  

  • 4. HMOs: looking behind the facade to establish true value.
    Millikan DL; Origer DL
    Healthc Financ Manage; 1987 Feb; 41(2):23, 26-9, 32-4. PubMed ID: 10280169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of incremental financial analysis to evaluate strategies: a case study.
    Kolb DS; Black GJ
    Top Health Care Financ; 1988; 15(1):82-92. PubMed ID: 3059579
    [No Abstract]   [Full Text] [Related]  

  • 6. Should your hospital affiliate with an HMO?
    Gregg SA
    Trustee; 1981 Jul; 34(7):37-9. PubMed ID: 10251881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formal hospital/HMO contracts increase: survey.
    Rahn GJ; Traska MR
    Hospitals; 1987 Jul; 61(14):47-8, 50. PubMed ID: 3596552
    [No Abstract]   [Full Text] [Related]  

  • 8. Risky business: reporting and recording issues for capitated HMOs.
    Kazahaya GI
    Healthc Financ Manage; 1986 Oct; 40(10):50-60. PubMed ID: 10278536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial, operational issues entangle Medicaid managed care.
    Kalkhof CJ
    Healthc Financ Manage; 1992 Aug; 46(8):26-8, 30, 32 passim. PubMed ID: 10145662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitals experiment with discounts, capitation rates under HMO contracts.
    Punch L
    Mod Healthc; 1984 Jan; 14(1):66. PubMed ID: 10264408
    [No Abstract]   [Full Text] [Related]  

  • 11. What determines hospital sponsorship of an HMO?
    McCue MJ
    Inquiry; 2000; 37(3):268-81. PubMed ID: 11111284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affiliation: when is it the right decision?
    Budd GB; Ross DJ
    Top Health Care Financ; 1988; 15(1):73-81. PubMed ID: 3201469
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying incremental cost in HMO/PPO bid evaluation.
    Annis RJ; Holton JW
    Health Prog; 1986 Apr; 67(3):26-8. PubMed ID: 10275904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakdown approach helps managers select projects.
    Cappettini R; Chow C; Williamson J
    Healthc Financ Manage; 1990 Nov; 44(11):48, 50, 52-6. PubMed ID: 10145342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The great HMO debate: will affiliation help or hinder your hospital's future?
    Cost Containment; 1980 Mar; 2(5):3-6. PubMed ID: 10245357
    [No Abstract]   [Full Text] [Related]  

  • 16. A good, hard look at IPAs.
    McMorran WC
    Health Manage Q; 1987; 9(4):9-11. PubMed ID: 10312335
    [No Abstract]   [Full Text] [Related]  

  • 17. Risky business: the risk-based, risk-sharing capitated HMO.
    Kazahaya GI
    Healthc Financ Manage; 1986 Aug; 40(8):70-3. PubMed ID: 10277301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Product life cycle: still a valid framework for business planning.
    Krentz SE; Pilskaln SM
    Top Health Care Financ; 1988; 15(1):40-8. PubMed ID: 3059576
    [No Abstract]   [Full Text] [Related]  

  • 19. Incorporating risk into the investment decision.
    Ryan JB; Gocke JL
    Top Health Care Financ; 1988; 15(1):49-65. PubMed ID: 3059577
    [No Abstract]   [Full Text] [Related]  

  • 20. Transition strategies: moving systems from old to new.
    Lemon RB; Meier JA
    Healthc Financ Manage; 1987 Jul; 41(7):56-8, 60, 62-5. PubMed ID: 10301693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.